Shalini Sharp - Insider Trading & Ownership

Entity
Individual
Location
C/O Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato, CA
Summary
The estimated net worth of Shalini Sharp is at least $3.02M dollars as of October 24, 2024. Shalini Sharp is the Director of BeiGene, Ltd. and owns shares of BeiGene, Ltd. (ONC) stock worth about $1.69M. Shalini Sharp is the Director of Organon & Co. and owns shares of Organon & Co. (OGN) stock worth about $763K. Shalini Sharp is the Director of NEUROCRINE BIOSCIENCES INC and owns shares of NEUROCRINE BIOSCIENCES INC (NBIX) stock worth about $564K.
All Insider Reports
All Insider Reports

Ownership of Shalini Sharp

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ONC, BGNE BeiGene, Ltd. Director $1.69M Sep 30, 2024
OGN Organon & Co. Director $763K Jun 7, 2024
NBIX NEUROCRINE BIOSCIENCES INC Director $564K -$157K -21.8% May 22, 2024
MRTX Mirati Therapeutics, Inc. Director Jan 23, 2024
DTIL PRECISION BIOSCIENCES INC Director May 10, 2021
SEPN Septerna, Inc. Director Oct 24, 2024
STRO SUTRO BIOPHARMA, INC. Director Jun 6, 2022

Insider Transactions Reported by Shalini Sharp:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.